https://www.hepatitisc.uw.edu/custom/test-cure/pretreatment-evaluation-fibrosis-staging/3/1
Core Concepts - Identifying Patients with Decompensated Cirrhosis - Pretreatment Evaluation and...
core conceptsidentifying patientsdecompensated cirrhosispretreatmentevaluation
https://cordis.europa.eu/project/id/847949/de
DECOMPENSATED CIRRHOSIS: IDENTIFICATION OF NEW COMBINATORIAL THERAPIES BASED ON SYSTEMS APPROACHES...
In 2013, cirrhosis was responsible for 1.2 million deaths worldwide. This mortality is mainly due to cirrhosis decompensation, i.e. development of ascites,...
decompensated cirrhosisbased onidentificationnew
https://www.hepatitisc.uw.edu/custom/test-cure/pretreatment-evaluation-fibrosis-staging/3/2
Activities - Identifying Patients with Decompensated Cirrhosis - Pretreatment Evaluation and...
identifying patientsdecompensated cirrhosisactivitiespretreatmentevaluation
https://pubmed.ncbi.nlm.nih.gov/35023891/
Decreased diversity of salivary microbiome in patients with stable decompensated cirrhosis
Patients with stable decompensated cirrhosis of various etiology and history of complications have decreased diversity of their salivary microbiome. PCoA and...
in patientsdecreaseddiversitymicrobiome
https://experts.arizona.edu/en/publications/progression-of-stage-2-and-3-acute-kidney-injury-in-patients-with/
Progression of Stage 2 and 3 Acute Kidney Injury in Patients With Decompensated Cirrhosis and...
https://pubmed.ncbi.nlm.nih.gov/41340228/
Serum Villin-1-A Novel Marker of Gut Barrier Damage in Acutely Decompensated Cirrhosis: A Cohort...
Serum VIL1 is a non-invasive indicator of gut barrier damage and short-term mortality in AD cirrhosis. Incorporating VIL1 assessment into risk stratification...
https://pubmed.ncbi.nlm.nih.gov/26901072/
The prognostic significance of bacterial DNA in patients with decompensated cirrhosis and suspected...
BactDNA in sterile body fluids did not indicate increased mortality in cirrhotic patients with suspected infection. Using multiplex PCR for risk stratification...